Search Results 741-750 of 1250 for ☃휴대폰소액결제현금화 (010-9675-8884) 카톡 ON8884 콘텐츠이용료소액결제☃

  1. Trial of Measles Virotherapy in Combination With Nivolumab in Patients With Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

    About this study. This a Phase 1 study designed to determine the maximum tolerated dose (MTD) and toxicity of attenuated Measles virus (MV-NIS) combined ...

  2. Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell ...

  3. A Study Biomarkers for Diagnosis, Disease Activity, Prediction of Response to Therapy and Prognosis in Spondyloarthritis - Mayo Clinic

    The purpose of this study is to establish a biorepository of biosamples from patients with spondyloarthritis (SpA). This biorepository will enable future ...

  4. A Study to Evaluate the Feasibility of Memantine in Reducing Cognitive Impairment in Pediatric Patients After Radiation Therapy for Central Nervous System Tumors - Mayo Clinic

    The purpose of this study is to evaluate the feasibility of twice daily memantine started before radiation therapy (RT) and continued one month after radiation ...

  5. Alisertib in Treating Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Using a Digital Phenotype in the Diagnosis and Prediction of Outcomes in Cirrhosis - Mayo Clinic

    The purpose of this study is to define a comprehensive digital phenotype through radio signal-enabled passive environment monitoring, associated with clinical ...

  7. Study to Distinguish Mood Disorders - Mayo Clinic

    The goal of this proposed study is to examine the genetic signature of the validated proteomic signature (model) based on a panel of serum proteomic markers ...

  8. Health Topics - Mayo Clinic News Network

    Peter James Dyck, M.D., professor emeritus of Neurology, passed away on July 26 at age 97. Dr. Dyck transformed the field of peripheral neuropathy. After[.

  9. Membership - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

    Faculty members conducting research through the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.

  10. A Study of Comparing of Hip Flexor Flexibility in Prone with the Modified Thomas Test Position - Mayo Clinic

    There are current gaps in our knowledge of the ability of clinicians to assess hip flexor muscle flexibility in different positions. The aim of this study is to ...